Ana Claudia Maretti Garcia, PhD
|
| Title(s) | Assistant Professor of Research Medicine |
|---|
| School | Keck School of Medicine of Usc |
|---|
| Address | 1450 Biggy St.
Health Sciences Campus
Los Angeles CA 90033
|
|---|
| Phone | +1 323 865 1240 |
|---|
ORCID
.gif) | 0000-0002-6252-2811  |
|---|
| vCard | Download vCard |
|---|
|
|
Biography
| Universidade Federal do Rio de Janeiro, Brazil | BS | 2004 | Biomedical Sciences |
| FIOCRUZ, Brazil | MS | 2006 | Parasitology |
| FIOCRUZ, Brazil | PhD | 2011 | Molecular and Cellular Biology |
| University of California, Los Angeles, Los Angeles | | 2013 | Post-doctoral, Immunology |
| Cedars-Sinai, Los Angeles | | 2014 | Post-doctoral, Molecular Immunology |
| University of Southern California, Los Angeles | | 2018 | Post-doctoral, Liver Biology |
| University of Southern California, Los Angeles | | 2021 | Post-doctoral, Liver Immunology |
| NIH | 2017
-
| 2018 | RCLD Young Investigator Award |
| American Association for the Study of Liver Diseases | 2016 | | Presidential Poster of Distinction |
| American Association for the Study of Liver Diseases | 2016 | | Basic Science Young Investigator Travel Award |
| Brazilian Society of Protozoology | 2007 | | Best Scientific Presentation Award |
Overview
Dr. Maretti-Garcia earned her B.S. degree in biomedical sciences, M.S. in Parasitology, and Ph.D. in Molecular and Cellular Biology in Brazil. After completing her postdoctoral training at the University of California, Los Angeles (UCLA), where she studied the immunopathology of tropical diseases, she joined the University of Southern California (USC) to study liver diseases.
Recently, Dr. Maretti-Garcia became an Assistant Professor at Keck School of Medicine of USC, and her research interest mainly concentrates on the contribution of the immune response to the progression of chronic liver diseases. She is an expert in cutting-edge technologies used for transcriptomic analyses and for real-time cellular behavior assays.
Research
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity. Frontiers in Virology. 2023; 3.
Maretti-Mira Ana C., Salomon Matthew P., Hsu Angela M., Matsuba Chikako, Golden-Mason Lucy. View Publication.
-
Editorial: New strategies for the treatment of diseases caused by trypanosomatid parasites. Front. Cell. Infect. Microbiol. 2023; 13.
Cardoso Flávia de Oliveira, Almeida-Souza Fernando, Maretti-Mira Ana Cláudia, Abreu-Silva Ana Lúcia. View Publication.
-
Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity. Front Immunol. 2023; 14:1137034.
Ana C Maretti-Mira, Matthew P Salomon, Angela M Hsu, Lily Dara, Lucy Golden-Mason. View Publication.
-
Hepatic damage caused by long-term high cholesterol intake induces a dysfunctional restorative macrophage population in experimental NASH. Front Immunol. 2022; 13:968366.
Ana C Maretti-Mira, Matthew P Salomon, Angela M Hsu, Gary C Kanel, Lucy Golden-Mason. View Publication.
-
Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes. PLoS Pathog. 2021 08; 17(8):e1009799.
Burchill MA, Salomon MP, Golden-Mason L, Wieland A, Maretti-Mira AC, Gale M, Rosen HR. PMID: 34370798; PMCID: PMC8376199.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCells
-
Cholesterol-Induced M4-Like Macrophages Recruit Neutrophils and Induce NETosis. Front Immunol. 2021; 12:671073.
Maretti-Mira AC, Golden-Mason L, Salomon MP, Kaplan MJ, Rosen HR. PMID: 34012454; PMCID: PMC8126646.
View in:
PubMed Mentions:
9 Fields:
Translation:
HumansCells
-
Susceptibility of Rat Steatotic Liver to Ischemia-Reperfusion Is Treatable With Liver-Selective Matrix Metalloproteinase Inhibition. Hepatology. 2020 11; 72(5):1771-1785.
Wang X, Walkey CJ, Maretti-Mira AC, Wang L, Johnson DL, DeLeve LD. PMID: 32060938; PMCID: PMC7523533.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansAnimalsCells
-
Sinusoids as Drivers of Liver Development: More Than Simple Chemistry. Hepatology. 2019 08; 70(2):737-739.
Maretti-Mira AC, DeLeve LD. PMID: 30681732.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansAnimalsCells
-
Incomplete Differentiation of Engrafted Bone Marrow Endothelial Progenitor Cells Initiates Hepatic Fibrosis in the Rat. Hepatology. 2019 03; 69(3):1259-1272.
Maretti-Mira AC, Wang X, Wang L, DeLeve LD. PMID: 30141211; PMCID: PMC6387651.
View in:
PubMed Mentions:
20 Fields:
Translation:
AnimalsCells
-
Liver-Selective MMP-9 Inhibition in the Rat Eliminates Ischemia-Reperfusion Injury and Accelerates Liver Regeneration. Hepatology. 2019 01; 69(1):314-328.
Wang X, Maretti-Mira AC, Wang L, DeLeve LD. PMID: 30019419; PMCID: PMC6325019.
View in:
PubMed Mentions:
16 Fields:
Translation:
Animals
-
Liver Sinusoidal Endothelial Cell: An Update. Semin Liver Dis. 2017 11; 37(4):377-387.
DeLeve LD, Maretti-Mira AC. PMID: 29272898; PMCID: PMC6005648.
View in:
PubMed Mentions:
72 Fields:
Translation:
HumansAnimalsCells
-
Severity of tegumentary leishmaniasis is not exclusively associated with Leishmania RNA virus 1 infection in Brazil. Mem Inst Oswaldo Cruz. 2013 Aug; 108(5):665-7.
Pereira Lde O, Maretti-Mira AC, Rodrigues KM, Lima RB, Oliveira-Neto MP, Cupolillo E, Pirmez C, de Oliveira MP. PMID: 23903986; PMCID: PMC3970596.
View in:
PubMed Mentions:
39 Fields:
Translation:
HumansAnimalsCells
-
Transcriptome patterns from primary cutaneous Leishmania braziliensis infections associate with eventual development of mucosal disease in humans. PLoS Negl Trop Dis. 2012; 6(9):e1816.
Maretti-Mira AC, Bittner J, Oliveira-Neto MP, Liu M, Kang D, Li H, Pirmez C, Craft N. PMID: 23029578; PMCID: PMC3441406.
View in:
PubMed Mentions:
18 Fields:
Translation:
HumansAnimalsCells
-
Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo. Antimicrob Agents Chemother. 2012 Feb; 56(2):658-65.
Erfe MC, David CV, Huang C, Lu V, Maretti-Mira AC, Haskell J, Bruhn KW, Yeaman MR, Craft N. PMID: 22123683; PMCID: PMC3264259.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansAnimalsCells
-
MMP-9 activity is induced by Leishmania braziliensis infection and correlates with mucosal leishmaniasis. Acta Trop. 2011 Aug; 119(2-3):160-4.
Maretti-Mira AC, de Pinho Rodrigues KM, de Oliveira-Neto MP, Pirmez C, Craft N. PMID: 21663729.
View in:
PubMed Mentions:
19 Fields:
Translation:
HumansAnimalsCells
-
Influence of the Notch system in the therapeutic response of American tegumentary leishmaniasis. Br J Dermatol. 2011 Jun; 164(6):1228-34.
Rodrigues KM, Oliveira MP, Maretti-Mira AC, Oliveira-Neto MP, Mattos MS, Silva L, Soares DA, Dolci EL, Perico RA, Pirmez C. PMID: 21299543.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression. Clin Exp Immunol. 2011 Feb; 163(2):207-14.
Maretti-Mira AC, de Oliveira-Neto MP, Da-Cruz AM, de Oliveira MP, Craft N, Pirmez C. PMID: 21091666; PMCID: PMC3043311.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
LXR deficiency confers increased protection against visceral Leishmania infection in mice. PLoS Negl Trop Dis. 2010 Nov 16; 4(11):e886.
Bruhn KW, Marathe C, Maretti-Mira AC, Nguyen H, Haskell J, Tran TA, Vanchinathan V, Gaur U, Wilson ME, Tontonoz P, Craft N. PMID: 21103366; PMCID: PMC2982826.
View in:
PubMed Mentions:
14 Fields:
Translation:
HumansAnimalsCells
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs